Monitor for signs and symptoms of infusion-related reactions. Interrupt or slow the rate of infusion for Grade 1 or Grade 2 reactions. For Grade 3 or Grade 4 reactions, stop infusion and permanently discontinue KEYTRUDA. Complicatio...
Jain: TNBC is a breast cancer that is more aggressive than some of the other types, and it's important to get the word out, as we're trying to make sure that all of our patients are keeping up with their screening and know about signs and symptoms to look out for. What is the cu...
Black patients were more likely to have a first-time mammogram due to identification of symptoms (72%) compared to White patients (58%). Oncologists perceived that few (4%) of their patients experienced barriers to mammogram access, though they perceived higher rates of barriers among Black ...
When given alongsidechemotherapy,Tecentriq(atezolizumab) increases the percentage of people with earlytriple-negative breast cancer(TNBC) who show no signs of cancer during tumor removal surgery, a Phase 3 trial shows. These results were found regardless of the ...
Additional exploratory PRO end points consisted of mean and mean changes from baseline in terms of function (emotional, social, and cognitive), as well as disease and/or treatment-associated symptoms; the proportion of patients reporting each response at each assessment time point by tre...
A delay of the onset of serum hormone postmenopausal status was observed compared with clinical symptoms. This interval was approximately 21 months in patients aged 46 to 49 years and 17 months in patients aged over 50 years. This interval is significant in the clinical ...
After four cycles, the patient developed symptoms consistent with Sjgren's syndrome (SjS), which were confirmed by diagnostic tests. Treatment wi th prednisone, pilocarpine and hydroxychloroquine was initiated alongside ongoing immunotherapy. The patient continues to receive atezoliz...